527 related articles for article (PubMed ID: 32310723)
21. Nanomaterials for ocular drug delivery.
Liu S; Jones L; Gu FX
Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
[TBL] [Abstract][Full Text] [Related]
22. Phenylboronic-Acid-Based Polymeric Micelles for Mucoadhesive Anterior Segment Ocular Drug Delivery.
Prosperi-Porta G; Kedzior S; Muirhead B; Sheardown H
Biomacromolecules; 2016 Apr; 17(4):1449-57. PubMed ID: 26963738
[TBL] [Abstract][Full Text] [Related]
23. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
[TBL] [Abstract][Full Text] [Related]
25. Topical delivery of aqueous micellar resolvin E1 analog (RX-10045).
Cholkar K; Gilger BC; Mitra AK
Int J Pharm; 2016 Feb; 498(1-2):326-34. PubMed ID: 26706439
[TBL] [Abstract][Full Text] [Related]
26. Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics.
Grimaudo MA; Pescina S; Padula C; Santi P; Concheiro A; Alvarez-Lorenzo C; Nicoli S
Expert Opin Drug Deliv; 2019 Apr; 16(4):397-413. PubMed ID: 30889977
[TBL] [Abstract][Full Text] [Related]
27. Principles of pharmacology in the eye.
Awwad S; Mohamed Ahmed AHA; Sharma G; Heng JS; Khaw PT; Brocchini S; Lockwood A
Br J Pharmacol; 2017 Dec; 174(23):4205-4223. PubMed ID: 28865239
[TBL] [Abstract][Full Text] [Related]
28. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
Andonova VY
Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
[TBL] [Abstract][Full Text] [Related]
29. Ocular preparations: the formulation approach.
Kaur IP; Kanwar M
Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond.
Destruel PL; Zeng N; Maury M; Mignet N; Boudy V
Drug Discov Today; 2017 Apr; 22(4):638-651. PubMed ID: 28017837
[TBL] [Abstract][Full Text] [Related]
31. Poloxamer 407/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery.
Grimaudo MA; Pescina S; Padula C; Santi P; Concheiro A; Alvarez-Lorenzo C; Nicoli S
Mol Pharm; 2018 Feb; 15(2):571-584. PubMed ID: 29313693
[TBL] [Abstract][Full Text] [Related]
32. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
33. Advance of the application of nano-controlled release system in ophthalmic drug delivery.
Wang X; Wang S; Zhang Y
Drug Deliv; 2016 Oct; 23(8):2897-2901. PubMed ID: 26635087
[TBL] [Abstract][Full Text] [Related]
34. Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone.
Mo Z; Ban J; Zhang Y; Du Y; Wen Y; Huang X; Xie Q; Shen L; Zhang S; Deng H; Hou D; Chen Y; Lu Z
Nanomedicine (Lond); 2018 Jun; 13(11):1239-1253. PubMed ID: 29949466
[TBL] [Abstract][Full Text] [Related]
35. Ophthalmic drug dosage forms: characterisation and research methods.
Baranowski P; Karolewicz B; Gajda M; Pluta J
ScientificWorldJournal; 2014; 2014():861904. PubMed ID: 24772038
[TBL] [Abstract][Full Text] [Related]
36. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronic acid modified MPEG-b-PAE block copolymer aqueous micelles for efficient ophthalmic drug delivery of hydrophobic genistein.
Li C; Chen R; Xu M; Qiao J; Yan L; Guo XD
Drug Deliv; 2018 Nov; 25(1):1258-1265. PubMed ID: 29847210
[TBL] [Abstract][Full Text] [Related]
38. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration.
Gote V; Ansong M; Pal D
Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):885-906. PubMed ID: 32729364
[TBL] [Abstract][Full Text] [Related]
39. Advances in ophthalmic drug delivery.
Morrison PW; Khutoryanskiy VV
Ther Deliv; 2014 Dec; 5(12):1297-315. PubMed ID: 25531930
[TBL] [Abstract][Full Text] [Related]
40. A review on recent drug delivery systems for posterior segment of eye.
Nayak K; Misra M
Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
